Blackstone Life Sciences
Venture capital · Cambridge, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio1 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Nuvation Bio
21Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Roivant Sciences | Biotech | Active | — | — |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
| Cerevel Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#136
Portfolio exits#103
Raises, 12 months#88
Co-investors#101
Co-investors
- Andreessen HorowitzVenture capital2 shared
- Deerfield Capital ManagementVenture capital2 shared
- AbbVieVenture capital1 shared
- Asahi Kasei Corporate Venture CapitalVenture capital1 shared
- Boxer CapitalVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- General CatalystVenture capital1 shared
- GVVenture capital1 shared
- Mayo ClinicVenture capital1 shared
- MedicxiVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.